scholarly journals Hymenolepis diminuta-based helminth therapy in C3(1)-TAg mice does not alter breast tumor onset or progression

2021 ◽  
Author(s):  
Scott Sauer ◽  
Dylan Beinart ◽  
Sade M B Finn ◽  
Sereena L Kumar ◽  
Qing Cheng ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Colon Cancer ◽  
Reproductive Factors ◽  
Hymenolepis Diminuta ◽  
High Rate ◽  
Western Society ◽  
Tumor Onset ◽  
Study Results ◽  
Intestinal Worms

Abstract Background and objectives An individual’s risk of breast cancer is profoundly affected by evolutionary mismatch. Mismatches in Western society known to increase the risk of breast cancer include a sedentary lifestyle and reproductive factors. Biota alteration, characterized by a loss of biodiversity from the ecosystem of the human body as a result of Western society, is a mismatch known to increase the risk of a variety of inflammation-related diseases, including colitis-associated colon cancer. However, the effect of biota alteration on breast cancer has not been evaluated. Methodology In this study, we utilized the C3(1)-TAg mouse model of breast cancer to evaluate the role of biota alteration in the development of breast cancer. This model has been used to recapitulate the role of exercise and pregnancy in reducing the risk of breast cancer. C3(1)-TAg mice were treated with Hymenolepis diminuta, a benign helminth that has been shown to reverse the effects of biota alteration in animal models. Results No effect of the helminth Hymenolepis diminuta was observed. Neither the latency nor tumor growth was affected by the therapy, and no significant effects on tumor transcriptome were observed based on RNAseq analysis. Conclusions and implications These findings suggest that biota alteration, although known to affect a variety of Western-associated diseases, might not be a significant factor in the high rate of breast cancer observed in Western societies. Lay Summary An almost complete loss of intestinal worms in high-income countries has led to increases in allergic disorders, autoimmune conditions, and perhaps colon cancer. However, in this study, results using laboratory mice suggest that loss of intestinal worms might not be associated with breast cancer.

scholarly journals The Assembly of a Criminal Self

2020 ◽  
Vol 24 (2) ◽  
pp. 43-61
Author(s):  
Seán Manning ◽  
Dave Nicholls
Keyword(s):  
Indigenous People ◽  
20Th Century ◽  
Natural Extension ◽  
The Self ◽  
High Rate ◽  
Western Society ◽  
Psychotherapeutic Intervention ◽  
Criminal Histories ◽  
History Of

Beginning with the experience of working with men in prison and others who have considerable prison experience, all of whom have long criminal histories, and considering Aotearoa’s relatively high rate of imprisonment, particularly of indigenous people, this paper attempts to describe a theory of self as a performative assembly, rather than as a developmental achievement, which is the dominant view in psychotherapy. In doing so, a brief history of the self from the beginning of the 20th century is presented, illustrating how the self changes, not just in an individual subjectivity, but between eras in the history of Western society. This perspective is used to understand how a “criminal self” might develop as a product of incarceration and as a natural extension of the self in the neoliberal era, and why it might prove resistant to psychotherapeutic intervention. Drawing on the work of Foucault, Rose, and Butler, among others, the concept of “intoxicating performativity” is introduced. The role of anger as an antidote to fragmentation is explored. Some thoughts are added about why indigenous people are overrepresented in prison compared to the population at large.

scholarly journals Circulating Nuclear Factor-Kappa B Mediates Cancer-Associated Inflammation in Human Breast and Colon Cancer

2020 ◽  
Author(s):  
Hafize Uzun ◽  
Berrin Papila Kundaktepe ◽  
Volkan Sozer ◽  
Pinar Kocael ◽  
Sinem Durmus ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Colon Cancer ◽  
Nuclear Factor Kappa B ◽  
Enzyme Linked Immunosorbent Assay ◽  
Nuclear Factor ◽  
Healthy Controls ◽  
Nuclear Factor Kappa ◽  
Tnf Α ◽  
Study Results ◽  
Serum Crp

Background: Inflammation is recognized as a hallmark feature of cancer development and progression. The aim of our study was to investigate the significance of serum nuclear factor kappa-B (NF-кB) levels as a circulating marker in the monitor of inflammation in breast and colon cancer; to show the relationship between NF-кB with inflammatory parameters as tumor necros faktor-α (TNF-α), soluble TNF-related apoptosis inducing ligand (sTRAIL), interleukin-6 (IL-6), pentraxin-3 (PTX-3), procalcitonin (PCT), and C-reactive protein (CRP) levels. Methods: Serum NF-кB, TNF-α, sTRAIL, IL-6, PTX-3, PCT, and serum CRP levels were measured using enzyme linked immunosorbent assay (ELISA) in 40 patients with breast cancer, 40 patients with colon cancer and 30 healthy controls. Results: The serum NF-кB, TNF-α, IL-6, PTX-3, PCT and serum CRP concentration was significantly higher and the serum sTRAIL concentration was significantly lower in patients with breast and colon cancer than in those with an healthy controls. NF-кB were positive correlated with CRP and negative corelated with sTRAIL. Conclusions: These results suggest that increased NF-кB may decrease the clinical efficacy of sTRAIL in solid tumour cells. There is relationship between inflammation and carcinogenesis so that the development of cancer occurs with chronic inflammation in breast and colon. The study results have shown that colon and breast cancer patients have increased systemic inflammation, as measured by increased circulating cytokines, and acute phase proteins, or by abnormalities in circulating cells. NF-кB may combine with other markers of the systemic inflammatory response in prognostic scores in cancer. In addition to surgical resection of the tumor, conventional radio- and chemotherapy for cancer treatment, the use of sTRAIL or other agonists for cancer therapy appeared a new potential therapy.  

scholarly journals Dietary consumption of phytochemicals and breast cancer risk in Mexican women

2009 ◽  
Vol 12 (6) ◽  
pp. 825-831 ◽  
Author(s):  
Luisa Torres-Sanchez ◽  
Marcia Galvan-Portillo ◽  
Mary S Wolff ◽  
Lizbeth Lopez-Carrillo
Keyword(s):  
Breast Cancer ◽  
Menopausal Status ◽  
Reproductive Factors ◽  
Premenopausal Women ◽  
Protective Role ◽  
Mexican Women ◽  
Dietary Consumption ◽  
History Of ◽  
High Dietary Intake

AbstractObjectiveTo perform an evaluation of selected phytochemicals intake and breast cancer (BC) risk in Mexican women.DesignWe conducted hospital-based case–control study.SettingMexico City between 1994 and 1996.SubjectsA total of 141 histologically confirmed BC cases were age-matched (±3 years) to an equal number of hospital controls. The reproductive history of each woman was obtained by direct interview. The dietary consumption of flavonols, flavones, flavan-3-ols, cinnamic acid, lariciresinol, pinoresinol, secoisolariciresinol, matairesinol and coumestrol was obtained by means of a validated FFQ.ResultsAmong postmenopausal women, high dietary intake of flavonols and flavones was associated with a significant reduction of BC risk (high v. low tertile: OR = 0·21, 95 % CI 0·07, 0·60, P for trend = 0·004 and OR = 0·29, 95 % CI 0·10, 0·82, P for trend = 0·025, respectively); consumption of lignans (lariciresinol and pinoresinol) showed a similar effect, but only among premenopausal women (high v. low tertile: OR = 0·32, 95 % CI 0·10, 0·99, P for trend = 0·051 and OR = 0·19, 95 % CI 0·06, 0·62, P for trend = 0·006, respectively).ConclusionsOur results support a protective role of specific dietary phytochemicals in BC risk by menopausal status, independent of other reproductive factors.

scholarly journals Electrolyte deficiency after the novel coronavirus infection and post-COVID asthenia

2021 ◽  
Vol 5 (5) ◽  
pp. 245-251
Author(s):  
E.Yu. Ebzeeva ◽  
◽  
O.D. Ostroumova ◽  
I.F. Krotkova ◽  
E.V. Mironova ◽  
...  
Keyword(s):  
Pathological Condition ◽  
Acute Infection ◽  
High Rate ◽  
The Novel ◽  
Specific Syndrome ◽  
Study Results ◽  
Somatic Disorders ◽  
Coronavirus Infection ◽  
Novel Coronavirus

Asthenia is a non-specific syndrome common in general practice and occurs in patients with acute and chronic somatic disorders, including infectious ones. The novel coronavirus infection (COVID-19) is one of the leading causes of severe and persistent asthenia. The hypothalamicpituitary- adrenal axis is essential for the development of asthenia since its dysfunction provoked by various factors (including infections) results in electrolyte metabolism impairment with hypokalemia and hypomagnesemia. This paper describes a hypothetical pathogenic mechanism of asthenia after the COVID-19, which implies over-activation of the renin-angiotensin-aldosterone system that, in particular, leads to hypokalemia. The role of pharmacotherapy prescribed for the COVID-19 is highlighted. Study results demonstrate a high rate of hypokalemia in patients with the COVID-19 and suggest a direct correlation between the severity of hypokalemia and the activity of viral infection. Furthermore, the detection of electrolyte abnormalities is essential in both acute infection and convalescence. Finally, the authors consider ways of relieving this pathological condition. KEYWORDS: novel coronavirus infection, COVID-19, post-infectious asthenia, angiotensin-converting enzyme, hypokalemia, hypomagnesemia. FOR CITATION: Ebzeeva E.Yu., Ostroumova O.D., Krotkova I.F. et al. Electrolyte deficiency after the novel coronavirus infection and post- COVID asthenia. Russian Medical Inquiry. 2021;5(5):245–251 (in Russ.). DOI: 10.32364/2587-6821-2021-5-5-245-251.

Achieving quality: Comparing recommendations for cancer care between NCCN and ESMO.

2013 ◽  
Vol 31 (15_suppl) ◽  
pp. 6579-6579
Author(s):  
Jennifer Gao ◽  
Geoffrey Calkins ◽  
Michael J. Birrer ◽  
Don S. Dizon
Keyword(s):  
Breast Cancer ◽  
Colon Cancer ◽  
Evidence Based Medicine ◽  
B Cell Lymphoma ◽  
The United States ◽  
Treatment Recommendations ◽  
High Rate ◽  
Partial Breast Irradiation ◽  
Evidence Based ◽  
Based Medicine

6579 Background: Guidelines for the treatment of cancer are in place in both the United States and Europe. However, specific recommendations that can be utilized as measures of quality care have not been evaluated in either guideline set, nor have they have been compared against one another. Our aim was to delineate the number of concrete treatment recommendations made using the PICO model for evidence-based medicine. Methods: Three authors (JG, GC, DD) independently reviewed treatment guidelines of the National Comprehensive Cancer Network (NCCN) and the European Society for Medical Oncology (ESMO) for three common cancers: 1) breast cancer; 2) colon cancer; 3) non-Hodgkin lymphoma (specifically diffuse large B-cell lymphoma and follicular lymphoma). The primary objective was to differentiate the concordant versus discordant recommendations. Recommendations were identified by first identifying all category 1 and 2 guidelines in ESMO, then finding the equivalent NCCN recommendations, and finally assessing their fulfillment of the PICO model (Patient/Problem – Intervention – Comparison – Outcome). Each recommendation was separately analyzed by the three aforementioned authors of this abstract. The results reflect the unanimous agreement of all three reporters. Results: Using PICO criteria, we identified a total of 46 recommendations (10 colon cancer, 22 breast cancer, and 14 in NHL). Concordance between NCCN and ESMO was 80, 86, and 100 percent, respectively. Discordance between NCCN and ESMO were noted in first line chemotherapy regimens in localized colon cancer and fluoropyridine as maintenance therapy in unresectable colon cancer; patients who should receive partial breast irradiation and chemotherapy regimens in the elderly with breast cancer. Conclusions: The number of actual recommendations that meet the PICO evidence-based medicine criteria is relatively small. However, comparing NCCN and ESMO, there is a high rate of agreement between guidelines reviewed regarding treatment recommendations. Our data suggest that it may be possible to identify specific measures of quality treatment as defined by evidence based medicine criteria.

scholarly journals Incidence of male breast carcinoma in North Uganda A survey at Lacor Hospital, Gulu, during 2009–2016

2021 ◽  
pp. 1-6
Author(s):  
Irene Pecorella ◽  
Tom Richard Okello ◽  
Martin David Okwang
Keyword(s):  
Breast Cancer ◽  
Breast Carcinoma ◽  
Early Recognition ◽  
Tumour Size ◽  
Male Breast ◽  
Sub Saharan Africa ◽  
High Rate ◽  
Symptom Duration ◽  
African Countries ◽  
Study Results

BACKGROUND: Little information is available on male breast cancer (MBC) incidence from sub-Saharan Africa. OBJECTIVE: This is a retrospective study on MBC in rural North Uganda, based on the pathology records of a private, non-profit, missionary hospital. METHODS: All male patients that had histological diagnosis of breast carcinoma from January 2009 to December 2016 were included in this study. RESULTS: In time span of 8 years, there were 337 consecutive breast cancer presentations, including 21 MBC (6.2%). The latter patients showed advanced disease (mean symptom duration: 20.3 months; mean tumour size: 5 cm;) skin ulceration and ipsilateral lymph node metastasis: 60%). The mean age was 60.52 years (from 30 to 85 yrs). Ductal infiltrating carcinoma was the prevalent histological type in our series (65%), followed by an unusually high rate of papillary carcinomas (15%). There appeared to be a prevalence for left breasts (11 LT versus 6 RT; 64.7%), a finding also observed in the majority of MBC. CONCLUSIONS: This study is representative of the scenario in Northern Uganda, where MBC accounts for 6.2% of breast cancers, More information on the occurrence and risk factors of this unusual neoplasm in African countries may prompt prevention of chronic liver disease and early recognition and treatment of MBC.

scholarly journals A comprehensive bioinformatic analysis of RanBP9 expression and the relation to prognosis in human breast cancer

Epigenomics ◽  
2021 ◽  
Author(s):  
Yiling Meng ◽  
Yingxia Ying ◽  
Meichao Zhang ◽  
Suning Zhang ◽  
Yuan Yao ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cell Cycle Progression ◽  
Bioinformatic Analysis ◽  
Genetic Alterations ◽  
Breast Cancer Patients ◽  
Cycle Progression ◽  
Study Results ◽  
Cancer Tissues ◽  
Tissue Microarray Analysis

Aim: To explore the role of RanBP9 in breast cancer. Materials & methods: Oncomine, TIMER, GEPIA, UALCAN, c-BioPortal databases and tissue microarray analysis were used in this study. Results: The expression level of RanBP9 is elevated in breast cancer tissues, which is associated with poor prognosis in breast cancer patients. RanBP9 exhibits genetic alterations and a decreased methylation level in cancer tissues. RanBP9 may also regulate cell cycle progression and is linked to tumor purity and the infiltrating levels of immune cells. Conclusions: RanBP9 may correlate with prognosis and immune infiltration in breast cancer, laying the foundation for future studies on the potential role of RanBP9 in breast cancer.

scholarly journals Reproductive Factors and Breast Cancer Risk in Palestine: A Case-control Study

2020 ◽  
Author(s):  
Nuha El Sharif ◽  
Imtithal Khatib
Keyword(s):  
Breast Cancer ◽  
Multivariate Analysis ◽  
Replacement Therapy ◽  
Oral Contraceptives ◽  
Case Control Study ◽  
Reproductive Factors ◽  
Case Control ◽  
Early Age ◽  
Control Study

Abstract Background: Early age at menarche, late age at menopause, and late age at first full-term pregnancy are linked to a modest increase in the risk of developing breast cancer (breast ca). Multiparity is related to an increased risk but multiple full-term pregnancies decrease the risk of breast cancers. This study aims to investigate the reproductive determinants of breast cancer among women in the West Bank of Palestine.Methods: A structured questionnaire was used to collect data in a case-control study; 237 registered cases and 237 controls aged 40 years old or more. A multivariate analysis model was used to adjust for the association between women’s reproductive factors and breast ca risk. Adjusted odds ratio (AOR) and 95% confidence interval (95% CI) are reported. This study was approved by Al Quds University Ethical Research Committee and the Ministry of Health research unit. All women provided written informed consent.Results: In the multivariate analysis, having menarche after 13 years of age, using oral contraceptives for more than two months, using hormone replacement therapy (HRT), and getting pregnant at an early age (≤18 years) significantly doubled the risk for breast ca. Women who used hormonal contraceptives were significantly associated with higher odds of having breast ca 6.37 compared to those who did not use them (p <0.05). Similarly, nulliparous women showed 6 times the odds of breast ca be compared with women with one or more children (p = 0.005). Also, the mother’s educational level; parental consanguinity marriage; and positive family history of breast ca be strong determinants for breast ca in this study. Conclusions: This study provides clear evidence of the role of using oral contraceptives and hormonal replacement therapy on women's breasts ca. Therefore, reproductive hormones use, whether as a birth control tool or in therapy, must be rationalized. More in-depth investigations are needed to identify the protective role of having children and breastfeeding practices on breast ca protection. Special attention should be considered for the special social and cultural factors related to sexual and reproductive issues among women in Palestine

scholarly journals Predictive role of HER2-status on the effectiveness of endocrine adjuvant treatment in postmenopausal breast cancer patients: a population-based cohort study

2020 ◽  
Author(s):  
Aglaia Schiza ◽  
Davide Mauri ◽  
Irma Fredriksson ◽  
Anna-Karin Wennstig ◽  
Antonios Valachis
Keyword(s):  
Breast Cancer ◽  
Cohort Study ◽  
Propensity Score ◽  
Propensity Score Matching ◽  
Endocrine Therapy ◽  
Population Based ◽  
Her2 Status ◽  
Her2 Positive ◽  
Study Results

Abstract Purpose There are conflicting results on the potential role of HER2-status on the efficacy of aromatase inhibitors (AIs) and tamoxifen (TAM) in patients with hormone receptor (HR)-positive breast cancer (BC). The purpose of this population-based cohort study was to investigate the potential benefit of AIs compared to TAM as adjuvant therapy in postmenopausal BC patients by HER2-status in the era of modern therapy with HER2-blockade. Methods A population-based cohort study was performed including all postmenopausal women diagnosed with HR-positive BC without distant metastasis between 2007 and 2012 in three healthcare regions in Sweden. We analyzed the breast cancer-specific survival (BCSS) and overall survival (OS) in two distinct cohorts (HER2-negative, HER2-positive) based on the type of endocrine therapy (ET) used. A propensity score matching was performed separately in the HER2-negative and HER2-positive cohorts, respectively. Results After propensity score matching, 4368 patients with HER2-negative and 214 patients with HER2-positive BC were available for analysis. In the HER2-negative cohort, an improved BCSS [Hazard Ratio (HR): 0.51; 95% confidence interval (CI): 0.34–0.77, p value < 0.001] and a trend toward improved OS (HR: 0.66; 95% CI: 0.41–1.08, p value = 0.093) in favor of AI-based therapy was observed. In the HER2-positive cohort, no statistically significant difference between AI-based ET and TAM was found in terms of either BCSS or OS, although the direction of HR was similar as in the HER2-negative cohort (HR for BCSS: 0.84; 95% CI: 0.14–5.04, p = 0.849; HR for OS: 0.62; 95% CI: 0.10–3.38, p = 0.345). Conclusion Our study results, based on propensity-matched cohorts, did not support any predictive value of HER2-status on endocrine therapy in postmenopausal BC patients. AI-based ET remains the treatment of choice for postmenopausal BC patients with HR-positive disease in the modern era of HER2-directed therapy irrespective of HER2-status.

Sign in / Sign up

Export Citation Format

Share Document